Embryonic stem (ES) cells have been regarded as a powerful resource for cell replacement therapy. In recent reports mouse ES cells have been successfully applied in the treatment of spinal cord injury, hereditary myelin disorder of the central nervous system, and diabetes mellitus. Another type of disease that could benefit from the availability of stem cell therapy is liver disease. However, for this potential to be realized, it is necessary to demonstrate the differentiation of ES cells into hepatocytes. To demonstrate the in vivo differentiation potential of mouse ES cells, we injected ES cells into the spleen of immunosuppressed nude mice. Histological analysis of teratomas derived from injected ES cells revealed that some areas contained typical hepatocytes arranged in a sinusoidal structure. The hepatic nature of these cells was further confirmed by showing that transcripts of liver-specific genes were present in the differentiated teratoma using reverse transcriptase-polymerase chain reaction and immunohistochemistry using several liver-specific antibodies including HEP-PAR, phenylalanine hydroxylase, and mouse N-system aminotransferase to identify the respective proteins in the differentiated hepatocytes. This is the first demonstration that mouse ES cells can differentiate in vivo into a mixed population of hepatocytes of varying maturity. This finding extends the potential use of ES cells in the cell replacement therapy by including its possible application for treating liver diseases.
INTRODUCTION
row stem cells, and reversibly immortalized hepatocytes (17, 25, 27) . Unfortunately, each of these cell types has Organ transplantation has been widely used to treat a its own shortcomings, such as the risk of tumorigenesis variety of chronic liver diseases, including inborn errors in using immortalized cells and the limited proliferation of metabolism, liver cirrhosis, and hepatoma. However, capacity of somatic stem cells, let alone the problem of limitations in transplantation therapy, such as high cost, MHC compatibility. donor shortage, immune rejection, and other complica-ES cells derived from the inner cell mass of mammations, call for the development of alternative treatments. lian blastocyst are well known for their potential to main-Recent studies show that it is possible to treat liver distain an undifferentiated state throughout an extended ease by cell therapy (5, 11) . Stem cell therapy, if possinumber of passages (10, 21) . Upon appropriate stimulable, will have a tremendous advantage over the tradition ES cells differentiate into various lineage of all tional manipulations in that introduced stem cells can three germ layers and thus can serve as a powerful repermanently repopulate degenerating hepatocytes in the source of cell replacement therapy (28). For example, patient's liver. Scientists have searched for a reliable cell transplantation of neural cells derived from mouse ES source that can differentiate into functional hepatocytes, cells successfully rescued defective neurons in the cenin candidates including adult liver stem cells, bone martral nervous system, proving their potential value in stem cell therapy (4, 22) . More recently, ES cells have been Animals shown to differentiate into insulin-secreting β-cells, Female nude mice of BALB/c genetic background which rescued the diabetic animal (2, 20, 29) . Furtherwere obtained from Japan SLC. 129/SvJ mice were purmore, the development of human ES cell lines has chased from The Jackson Laboratory (Bar Harbor, ME). opened a new potential usage of ES cells as an excellent All mice were maintained on a 12-h light/12-h dark cysource for cell replacement therapy in various human cle and kept in a pathogen-free environment. diseases (25, 26, 30) . Together with the technical avail-ES Cell Transplantation ability in the cloning of mammalian cells, it is now conceivable to generate a patient's own ES cell line for de-Mice were anesthetized by IP injection of Avertin veloping desired stem cells (28).
solution. The spleen was exteriorized through a 1-cm Experimentally, mouse ES cells have been shown to incision on the left flank, and 10 6 undifferentiated ES differentiate into many specialized cell types including cells suspended in 100 µl of PBS were injected into the neural cells, cardiac and skeletal muscle cells, hematoinferior pole of the spleen using a 29-gauge needle. An poietic cells, adipocytes, chondrocytes, and osteoclasts (7, equal number of ES cells was injected into the hind leg 9,16, 18, 23, 32, 33) . During in vitro differentiation ES muscle in a similar manner. cells express endoderm markers such as α-fetoprotein, Analysis of ES Cell-Derived Teratoma albumin, and hepatocyte nuclear factor 3 (HNF3), suggesting their potential to differentiate into hepatocytes Three weeks after the transplantation of ES cells, (1, 14, 19) . However, there has been no report describing spleens were removed from the injected nude mice, the differentiation of ES cells into hepatocytes in vivo.
fixed in 10% formaldehyde, and embedded in paraffin. To realize the potential use of ES cells in cell replace-Sections were prepared and stained with hematoxylin ment therapy of liver diseases, it is important to formally and eosin (H&E) for histological examination. demonstrate their ability to differentiate into functional Immunohistochemistry hepatocytes. Here we report the first demonstration that mouse ES cells can differentiate into functional hepato-
The antihepatocyte antibody HEP-PAR, a mouse monoclonal antibody raised against human hepatocytes, cytes when injected into the immunosuppressed nude mouse. and horseradish peroxidase (HRP)-conjugated secondary antibody against mouse IgG were purchased from DAKO MATERIALS AND METHODS (Copenhagen, Denmark). The rabbit polyclonal antibody Cell Culture against human α-fetoprotein was purchased from Quartett (Berlin, Germany) and the mouse monoclonal anti-The 129/SvJ ES cell line used in this experiment is a subcell line of J1 ES cells that was originally established body PH8 recognizing a common epitope of human phenylalanine hydroxylase, tryptophan hydroxylase, and by Dr. Rudolph Jaenisch. Cells were maintained on the feeder of mitomycin-C-treated primary mouse embry-tyrosine hydroxylase was purchased from Chemical International (Temecula, CA). HEP-PAR antibody was di-onic fibroblasts in Dulbecco's modified Eagle's medium supplemented with 15% fetal bovine serum (FBS) (Gibco luted 1:40, α-fetoprotein antibody was used without dilution, PH8 antibody was diluted 1:200, and mNAT BRL, Gaithersburg, MD), 0.1 mM β-mercaptoethanol, 1000 U/ml leukemia inhibitory factor (LIF) (Gibco BRL), antibody was diluted 1:400 for immunostaining. Immunostaining was carried out with EnVision kit (DAKO) and 1× nonessential amino acid. The ES cells received at passage 10 were passaged four more times before following the manufacturer's instructions. Briefly, the deparaffinized sections were microwaved in target re-freezing in liquid nitrogen. Frozen vials of ES cells were thawed and passed three more times before transplanta-trieval buffer for 20 min and blocked for endogeneous peroxidase by incubating in the peroxidase block solu-tion. The feeder fibroblasts were prepared from C57BL/ 6J embryos of 13.5-16.5 days postcoitum. Briefly, after tion for 10 min. The sections were incubated with primary antibody for 30 min at room temperature and removal of soft tissues including the heart, liver, and other viscerae, the remains of embryo were minced in 2 washed with PBS three times for 5 min each. The sections were then incubated in EnVision solution for 30 ml of typsin-EDTA solution (0.05% trypsin and 0.5 mM EDTA) and passed through a 200-µm mesh. After cen-min and washed as before, and then treated with chromogenic substrate solution for 10 min. After a 90-s trifugation, the cell pellets were resuspended in DMEM with 10% FCS, cultured again until confluent, and resus-counterstaining with hematoxylin, sections were dehydrated, cleared, and mounted. pended in 2 ml freezing medium. The frozen feeder aliquots were thawed and cultured until confluent, and Periodic Acid-Shiff Histochemical Staining treated with 10 µg/ml mitomycin in DMEM with 10%
Deparaffinized tissue sections were immersed in peri-NCS for 3 h at 37°C, washed three times with PBS, and odic acid solution for 5 min at room temperature and plated on a gelatin-coated dish as a feeder layer. RT-PCR reaction are listed in Table 1 .
RESULTS
ES cells were transplanted influenced differentiation of the cells. The hepatocyte-like cells in the teratoma with To determine whether ES cells differentiate into hetypical large nucleus and abundant cytoplasm were arpatocytes in vivo, we introduced undifferentiated mouse ranged in a cord-like, sinusoidal structure (Fig. 1D ). The ES cells derived from the 129/SvJ strain into the spleen ES cell-derived teratoma in the nude spleen also conand hind leg muscle of syngenic mice. Three weeks tained other types of differentiated cells including panlater, teratomas formed from the transplanted ES cells creatic cells, primitive thyroid follicular cells, chondrowere histologically analyzed to determine the types of cytes, striated muscle cells, gut-like epithelium, and cells present in the tumors. The teratomas were mainly salivary gland-like cells (Fig. 2 ). Among these cells, gutcomposed of neuroectodermal cells and primitive neulike epithelium, primitive salivary gland-like cells, and roectodermal cells in the hind leg and spleen of the primitive thyroid follicular cells were positively stained syngenic 129/SvJ mouse, respectively (Fig. 1A, B ). As by periodic acid-Shiff (PAS), confirming their identity an alternative, the ES cells were introduced into the (Fig. 2F, H) . spleen of immunosuppressed nude mice. In contrast to We next investigated mRNA expression level of the teratomas that developed in the syngenic mice, the genes that are known to be expressed in hepatocytes teratoma formed in the inferior pole of nude mouse (Fig. 3 ). Oct-4, the only known transcription factor inspleen contained cells showing morphological charactervolved in the pluripotency of embryos, is highly existics of hepatocytes (Fig. 1C, D) . Similar experiments pressed in the undifferentiated ES cells, although a cerwere repeated 10 times and produced comparable results, indicating that the microenvironment in which the tain level of expression was also detected in the ES teratoma (20, 24, 34) . Many hepatic genes, including al-fetoprotein antibody recognized some but not all cells in the hepatic area ( Fig. 4C, D) , suggesting that the hepato-bumin, α-fetoprotein, phenylalanine hydroxylase (PAH), α-1-antitrypsin, HNF-3β, aldolase B, tyrosine amino-cytes in the area are heterogeneous.
To confirm the ES cell-derived hepatocytes produce transferase (TAT), and ApoA1, were highly expressed in the teratoma but not detected in the undifferentiated functional enzymes, we analyzed the expression of PAH, which is specifically expressed in the liver (15). ES cells. On the other hand, transthyretin, transferrin, dipeptidyl peptidase IV (DDIV), and ApoA2 were ex-PH8 antibody recognizing PAH reacted strongly with cells in the hepatic region of ES teratoma, which stained pressed in certain levels in the undifferentiated ES cells and increased their levels in the teratoma.
with HEP-PAR antibody in serial sections (Fig. 5A ). Another protein, mouse N-system amino acid transporter The hepatic nature of cells in the ES cell-derived teratoma was further confirmed by an immunohistochemis-(mNAT), was also investigated on the teratoma sections. mNAT is a membrane-bound protein predominantly ex-try analysis using hepatocyte-specific antibodies. An antihepatocyte antibody, HEP-PAR, has been widely pressed in adult liver and functions in transporting amino acid across the cytoplasmic membrane specifi-used for the detection of human hepatocytes in various metastasized tumors (8, 31) . The HEP-PAR antibody cally for histidine and glutamine (13). Anti-mNAT antibody interacted with only a few of the cells in the he-specifically immunostained the ES cell-derived hepatocytes with sinusoidal structure with high affinity (Fig. patic area of the teratoma (Fig. 5C ). In addition, a small number of the ES cell-derived hepatocytes were stained 4A, B), indicating that the hepatic area in the teratoma contained matured hepatocytes. To further confirm the with PAS, which recognizes mucopolysaccharide (Fig.  5E ). PAS has been used to determine the storage of gly-hepatic lineage of the ES cells, an antibody against αfetoprotein, a well-known marker of embryonic hepato-cogen, which is abundant in functional hepatocytes of adult liver. These results lead to an implication that the cyte, was used to immunostain the teratomas. The α- ES cell-derived hepatocytes are functionally mature, and into neuroectodermal lineage, the cells injected into immunosuppressed nude mice underwent differentiation ES cells can differentiate in vivo into a mixed population of hepatocytes of varying maturity.
into diverse cell types including hepatocytes. In addition, the ES cell-derived teratomas developed in the leg DISCUSSION muscle of nude mice did not contain any hepatocyte-like By virture of its pluripotency and enormous proliferacells but mostly consisted of cells of ectodermal origin tion capacity, ES cells are considered to be the ideal (data not shown). Previously genetic and epigentic desource for cell replacement therapy. Recently ES cells terminants and immune factors in the host vs. graft have been reported to differentiate in vitro into cells of tissue have been reported to regulate teratogenesis of endodermal origin that express proper endodermal and transplanted early embryo (6) . The signals coming from hepatic markers (14). However, no histological or mothe surrounding spleen might affect the hepatic differenlecular characterization has yet been made either in vitro tiation of injected ES cells. It will be important to idenor in vivo to confirm the identity of these hepatocytetify these factors and understand how they govern the like cells. Our results provide the first histological and process of ES cell differentiation. immunohistological demonstration of the potential of ES Interestingly, the cells in the hepatic area of ES cellcells to differentiate into hepatocytes expressing proper derived teratoma appear to express different levels of markers. Not only do the ES cell-derived hepatocytes hepatic markers, such as α-fetoprotein, HEP-PAR antiexpress hepatocyte-specific markers, but they also exgen, PAH, and mNAT, and also differ in the amount of hibit characteristics of normal mature hepatocytes (e.g., cellular storage of glycogen, indicating that a given area the expression of PAH and mNAT and the cytoplasmic is populated with hepatic cells in varying stages of difaccumulation of glycogen).
ferentiation. During organogenesis of the embryo, the It appears that the microenvironment surrounding the liver bud formed by the proliferation of gut endodermal introduced ES cells has a great influence on the direccells is populated mostly by hepatoblasts expressing cytions of their differentiation. While the ES cells injected tokeratins common to both hepatocytes and bile duct into the syngenic 129/SvJ mice mainly differentiated cells, and then the subsequent expression of α-fetopro- tein and albumin by most hepatic cells identifies hepato-toma confirmed the highly differentiated status of hepatocytes, which expressed hepatic enzymes usually found cytic lineage (3, 12) . During this lineage establishment α-fetoprotein is transiently expressed and a large num-only in postnatal liver. Therefore, the hepatic area of the teratoma appears to comprise immature hepatocytes, ber of metabolic enzymes including PAH are induced within the hepatocytes during the perinatal period. mature hepatocytes, and fully functional hepatocytes. The apparent heterogeneity in the differentiation status Based on our results, the 13.5-16.5-day mouse embryonic liver does not express HER-PAR antigens, while suggests that these ES cell-derived hepatocytes are in the process of maturation, very likely recapitulating the the antigen was detected in the hepatocyte lineage cells of neonatal mouse liver, 2-week-old and 2-month-old pattern of normal hepatic cell differentiation during liver development. mouse liver, suggesting that HER-PAR antigen is expressed only in the mature hepatocyte (data not shown).
In order to study the functional potential of the ES cell-derived hepatocytes, it should be possible to isolate In addition, RT-PCR results of the ES cell-derived tera- 
